VNDA Hisse Senedi Fiyat Grafiği
VNDA Hisse Fiyat Tahmini
Vanda Pharmaceuticals Inc
$7.44
0.67%
$0.05
Kapanışta: May 06, 16:00:00 GMT-4
$7.25
-2.55%
$-0.19
Ön Piyasa: May 07, 06:12:14 GMT-4
Geri
Vanda Pharmaceuticals Inc (VNDA) Hisse Fiyat Tahmini
Önemli İstatistikler
Önceki Kapanış
$7.39
Açılış fiyatı
$7.51
Günün Aralığı
$7.25 - $7.73
52 haftalık aralık
$3.8 - $9.94
İşlem hacmi
1.6M
Ort.Hacim
2.4M
Dividend yield
--
EPS (TTM)
-3.74
Piyasa Değeri
$428.5M
VNDA nedir?
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The company is headquartered in Washington, Washington Dc and currently employs 533 full-time employees. The company went IPO on 2006-04-12. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.
